The estimated Net Worth of Robert Earle Grove is at least $190 Tausend dollars as of 2 December 2021. Robert Grove owns over 1,644 units of IRIDEX stock worth over $189,529 and over the last 6 years he sold IRIX stock worth over $0. In addition, he makes $0 as Independent Director at IRIDEX.
Sign up
Robert Grove IRIX stock SEC Form 4 insiders trading
Robert has made over 6 trades of the IRIDEX stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 1,644 units of IRIX stock worth $9,996 on 2 December 2021.
The largest trade he's ever made was buying 15,125 units of IRIDEX stock on 15 May 2020 worth over $25,410. On average, Robert trades about 4,084 units every 84 days since 2018. As of 2 December 2021 he still owns at least 93,364 units of IRIDEX stock.
You can see the complete history of Robert Grove stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Grove biography
Dr. Robert Earle Grove serves as Independent Director of the Company. Dr. Grove currently serves as an advisor to two early-stage medical device companies and was awarded a Presidential Citation at the 2019 annual meeting of the American Society for Laser Medicine and Surgery. Most recently he served as Executive Chairman for the start-up ON Light Sciences, a manufacturer of transparent gel patches for accelerated tattoo removal that was acquired by Merz North America in 2016. He was a founder and President and CEO of Intellectual Light, Inc. and Once Again Me, Inc., two startups focused on laser diode technology. Dr. Grove holds a Ph.D. in Instrumentation in the field of laser applications and an M.S. degree in Aeronautics and Astronautics from MIT, as well as a B.S. degree in Engineering Physics from Cornell University.
How old is Robert Grove?
Robert Grove is 71, he's been the Independent Director of IRIDEX since 2019. There are 1 older and 8 younger executives at IRIDEX. The oldest executive at IRIDEX Corp. is Robert Gunst, 72, who is the Independent Chairman of the Board.
What's Robert Grove's mailing address?
Robert's mailing address filed with the SEC is 1212, Terra Bella Avenue, Mountain View, Santa Clara County, California, 94043, United States.
Insiders trading at IRIDEX
Over the last 21 years, insiders at IRIDEX have traded over $1,952,092 worth of IRIDEX stock and bought 1,330,571 units worth $7,196,100 . The most active insiders traders include Joshua Makower, James B Hawkins und Capital Fund, Lp Acuta. On average, IRIDEX executives and independent directors trade stock every 32 days with the average trade being worth of $18,723. The most recent stock trade was executed by Nandini Devi on 20 May 2022, trading 2,000 units of IRIX stock currently worth $6,200.
What does IRIDEX do?
iridex corporation, founded in 1989, is a worldwide leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices. we offer laser based solutions for multiple specialties including aesthetic medicine, ophthalmology, and otolaryngology. we also maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. with superior technology for superior results, iridex is dedicated to standards of excellence that meet your own.
What does IRIDEX's logo look like?
Complete history of Robert Grove stock trades at IRIDEX
IRIDEX executives and stock owners
IRIDEX executives and other stock owners filed with the SEC include:
-
David Bruce,
President, Chief Executive Officer, Director -
Fuad Ahmad,
Interim Chief Financial Officer -
Patrick Mercer,
Chief Operating Officer -
David I. Bruce,
Pres, CEO & Director -
Patrick Mercer,
Chief Operating Officer -
Fuad Ahmad,
Interim Chief Financial Officer -
Doris Engibous,
Independent Director -
Lynn Lewis,
IR Contact Officer -
Robert Gunst,
Independent Chairman of the Board -
Scott Shuda,
Independent Director -
Kenneth Ludlum,
Independent Director -
Robert Grove,
Independent Director -
Leigh Salvo,
Head of Investor Relations -
George R Marcellino,
Director -
Capital Partners, L.P.Blue ...,
-
Ruediger Naumann Etienne,
Director -
Romeo R Dizon,
-
Sanford Fitch,
Director -
Atabak Mokari,
CFO and VP Corp Development -
Ronald Steckel,
VP, Operations -
Capital Partners, L.P.Blue ...,
-
Associates & Paragon Associ...,
-
William M Moore,
Director -
James H Mackaness,
Chief Financial Officer -
Barry G Caldwell,
President and CEO -
Larry Tannenbaum,
Chief Financial Officer -
James L Donovan,
VP, Corporate Business Develp. -
Beverly A Huss,
Director -
Ann D Rhoads,
Director -
Maria Sainz,
Director -
Ken Ludlum,
Director -
Capital Fund, Lp Acuta,
10% owner -
John M Nehra,
Director -
Joshua Makower,
Director -
Nandini Devi,
Director -
Capital Partners, L.P.Blue ...,
-
Catalyst Fund Ix, L.P.Blue ...,
-
Catalyst Fund Ix, L.P.Blue ...,
-
James B Hawkins,
Director -
Garrett A Garrettson,
Director -
Catalyst Fund Ix, L.P.Blue ...,
-
Eduardo Arias,
Sr. VP, Int'l Sales & Bus... -
Robert K Anderson,
Director -
Partners, L.L.C.Blue Line P...,
-
Dominik Beck,
President and CEO -
Partners, L.L.C.Blue Line C...,
-
Donald J Todd,
VP Marketing -
Capital Partners Ii, L.P.Bl...,
-
Partners, L.L.C.Blue Line C...,
-
Theodore A Boutacoff,
President and CEO -
Timothy S Powers,
Vice President, Operations -
Partners, L.L.C.Blue Line C...,
-
Partners, L.L.C.Blue Line P...,
-
Donald L Hammond,
Director -
Partners, L.L.C.Blue Line C...,
-
Partners, L.L.C.Blue Line C...,